Search results for: 'Cancer Diagnostics Market, liquid biopsy'

AI-powered molecular diagnostics is an emerging and moderately fragmented industry that includes molecular diagnostics companies, precision medicine platforms, sequencing specialists, AI-driven analytics providers, and disease-focused biotechnology companies. No single company has dominated, presenting opportunities for innovation. There has been a...

According to the National Institute of Health (NIH), there are more than 80 types of autoimmune diseases, of which less than 30 are diagnosable. Being 1 of the top 10 causes of death in the United States, there is a critical need in the market for the diagnosis and the treatment of both systemic diseases, such as lupus and rheumatoid arthritis, as ...

This research service evaluates the Western European cancer IVD market for Germany, the United Kingdom, Italy, Spain, France, Benelux and Scandinavia from 2010 to 2019. Beginning with an overview of the main market metrics and trends, the study identifies the key market drivers and restraints, evaluates ongoing competitive trends with detailed mark...

Accounting for 2%-3% of total healthcare expenditure and influencing 70% of clinical decision-making, diagnostics is the silent champion supporting all stages of precision health, including risk stratification, screening, early diagnosis, prognosis, monitoring, and relapse. The discovery and translation of blood-based neurology biomarkers, sustai...

19 Jun 2024  |  Global  |  Technology Research

Molecular Diagnostics for Neurodegenerative Diseases: Technology Growth Opportunities, 2024 2028

Leveraging integrated and point-of-care diagnostics with multiomics represents the most promising growth opportunity to advance molecular diagnostics for neurodegenerative diseases

Infographics

×

Neurodegenerative diseases (NDD) pose significant challenges to healthcare systems and affect millions of people worldwide, making early detection crucial. While the current diagnostic strategy is predominantly brain imaging techniques, it is not performed until symptoms are more pronounced. Subtle changes occurring in neural cells during early pro...

20 Jan 2025  |  Global  |  Market Research

Global Cardiac Biomarkers Diagnostics Industry, 2024-2029

Rising Prevalence of CVD and High Sensitivity POCT Driving Transformational Growth in Cardiac Biomarkers Diagnostics

Infographics

×

The global cardiac biomarkers diagnostics market is forecast to record robust growth with the increased prevalence of cardiovascular disease (CVD), multiplex biomarkers, advancements in diagnostic testing technology, higher POCT adoption rates, and an intensive focus on preventive healthcare. CVDs are a leading cause of mortality globally, highligh...

The Asia-Pacific next-generation diagnostics market's revenue is projected to decline by 5.0% in 2023, attributed to the reduced demand for COVID-19-related testing. Rapid expansion in non-COVID molecular diagnostics and point-of-care testing (POCT) will not be sufficient to drive the overall recovery of the region. As companies continue to focus o...

The market for Ionic Liquids is gaining momentum in recent years mainly due to its capability for sustainable replacement of traditional organic solvents in many industrial applications. In certain industries, ionic liquids can also be considered as green chemistry as they reduce or eliminate the use and generation of hazardous substances in many ...

17 Jun 2024  |  Global  |  Market Research

Diagnostics Lab Automation and Monitoring Solutions Growth Opportunities

The Intersection of Automation and Digital Data Exchange Unlocks Value for Diagnostics Labs

Infographics

×

The pathology workforce shortage, accuracy concerns, and uneven distribution of prices and resources are persistent challenges for the diagnostics sector. Lab test results are the foundation of future human health, influencing 70% of clinical decisions. A surge in lab tests yearly volume will result from persistent trends, including aging popu...